Stock Rich List
#1169 on the rich list of 14,452 insiders

Leon O. Moulder Jr.

Director at Dianthus Therapeutics; Chief Executive Officer at Zenas BioPharma; Director at Zai Lab. Based in Cambridge, Massachusetts.

$138M
in disclosed stock, +$435K (+0.32%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
1169th of 14,452
Companies held
3
Largest holding
DNTH, 88.4% of total
Latest SEC filing
Jun 17, 2026
Listed but not counted
$194M

What the $138M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Dianthus Therapeutics DNTH
Common Stock
Indirectly (see filing footnote)1,436,745$84.83$122M88.4%Form 4, Jan 22, 2024
Zenas BioPharma ZBIO
Common Stock
Directly423,155$25.04$10.6M7.7%Form 4, May 18, 2026
Zenas BioPharma ZBIO
Common Stock
Through Leon O. Moulder, Jr. Revocable Trust96,928$25.04$2.4M1.8%Form 4, May 18, 2026
Zai Lab ZLAB
American Depositary Shares
Directly94,973$21.92$2.1M1.5%Form 4, Jun 17, 2026
Zenas BioPharma ZBIO
Common Stock
Indirectly (see filing footnote)36,928$25.04$925K0.7%Form 4, Jan 7, 2026

Share counts are the amounts Leon O. Moulder Jr. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Leon O. Moulder Jr.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Dianthus Therapeutics DNTH
Common Stock
Through Tellus BioVentures, LLC
Held by a company or fund the insider manages
1,270,078$84.83$108M—Form 3, Sep 11, 2023
Zenas BioPharma ZBIO
Common Stock
Through Tellus BioVentures LLC
Held by a company or fund the insider manages
1,786,039$25.04$44.7M—Form 4, May 18, 2026
Zenas BioPharma ZBIO
Common Stock
Through Tellus BioVentures LLC
Held by a company or fund the insider manages
1,672,039$25.04$41.9M—Form 4, Oct 7, 2025

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
May 18, 2026BoughtZBIO60,000$16.88$1.0MView
Apr 29, 2026BoughtZBIO35,000$17.62$617KView
Apr 28, 2026BoughtZBIO25,000$18.02$451KView
Mar 31, 2026BoughtZBIO34,000$19.31$657KView
Mar 30, 2026BoughtZBIO20,000$18.23$365KView
Feb 2, 2026BoughtZBIO57,000$17.96$1.0MView
Jan 9, 2026BoughtZBIO20,000$16.55$331KView
Jan 8, 2026BoughtZBIO30,000$16.30$489KView
Jan 7, 2026BoughtZBIO50,000$16.38$819KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
1166Sudhir Srivastava
Chairman and CEO, SS Innovations International. Fort Lauderdale, FL
$139M−$3.3M (−2.29%)
1167William Austin Musselman Jr.
Director, Brown-Forman. Louisville, KY
$138M−$3.1M (−2.16%)
1168Srinivasan Sivaram
President, Tech & Strategy, Western Digital. San Jose, CA
$138M+$2.8M (+2.05%)
1169Leon O. Moulder Jr.
Director, Dianthus Therapeutics. Cambridge, MA
$138M+$435K (+0.32%)
1170Kevin J. Jacobs
See Remarks, Hilton Worldwide Holdings. Mclean, VA
$138M−$4.1M (−2.87%)
1171Scott W. Hart
Chief Executive Officer, StepStone Group. New York, NY
$138M+$722K (+0.53%)
1172Harry L. You
Director, IonQ. Las Vegas, NV
$137M−$1.3M (−0.92%)

Other Dianthus Therapeutics insiders

All DNTH insiders

Questions

How much stock does Leon O. Moulder Jr. own?

Leon O. Moulder Jr. holds $137,908,442 in listed stock based on SEC filings and current prices, mostly Dianthus Therapeutics (DNTH). That ranks 1169th on the Stock Rich List.

Is this Leon O. Moulder Jr.'s net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Leon O. Moulder Jr. last buy or sell stock?

The most recent open-market trade on file is a purchase of 60,000 ZBIO shares on May 18, 2026 at $16.88.